Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Pharmaceutic-company

HEALTH-CORONAVIRUS/USA
RTS3943N
May 26, 2020
U.S. ‪Vice President Mike Pence‬ looks on as President Donald Trump speaks about negotiations with pharmaceutical...
Washington, UNITED STATES
Pence looks on U.S. President Trump speaks about negotiations with pharmaceutical companies over the...
U.S. ‪Vice President Mike Pence‬ looks on as President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS39435
May 26, 2020
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of...
Washington, UNITED STATES
U.S. President Trump speaks about negotiations with pharmaceutical companies over the cost of insulin,...
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS39434
May 26, 2020
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of...
Washington, UNITED STATES
U.S. President Trump speaks about negotiations with pharmaceutical companies over the cost of insulin,...
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS3942Z
May 26, 2020
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of...
Washington, UNITED STATES
U.S. President Trump speaks about negotiations with pharmaceutical companies over the cost of insulin,...
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS3942Y
May 26, 2020
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of...
Washington, UNITED STATES
U.S. President Trump speaks about negotiations with pharmaceutical companies over the cost of insulin,...
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS3942X
May 26, 2020
White House staff members in masks listen as U.S. President Donald Trump speaks about negotiations with...
Washington, UNITED STATES
Staff members in masks listen as U.S. President Trump speaks about negotiations with pharmaceutical companies...
White House staff members in masks listen as U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS3942W
May 26, 2020
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of...
Washington, UNITED STATES
U.S. President Trump speaks about negotiations with pharmaceutical companies over the cost of insulin,...
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS3942V
May 26, 2020
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of...
Washington, UNITED STATES
U.S. President Trump speaks about negotiations with pharmaceutical companies over the cost of insulin,...
U.S. President Donald Trump speaks about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS3942M
May 26, 2020
U.S. President Donald Trump departs after speaking about negotiations with pharmaceutical companies over...
Washington, UNITED STATES
U.S. President Trump departs after speaking about negotiations with pharmaceutical companies over the...
U.S. President Donald Trump departs after speaking about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS3942L
May 26, 2020
U.S. President Donald Trump listens to questions from reporters after speaking about negotiations with...
Washington, UNITED STATES
U.S. President Trump listens to questions from reporters after speaking about negotiations with pharmaceutical...
U.S. President Donald Trump listens to questions from reporters after speaking about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS3942J
May 26, 2020
U.S. President Donald Trump departs after speaking about negotiations with pharmaceutical companies over...
Washington, UNITED STATES
U.S. President Trump departs after speaking about negotiations with pharmaceutical companies over the...
U.S. President Donald Trump departs after speaking about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS3942I
May 26, 2020
U.S. President Donald Trump beckons his guests to join him in the Oval Office after speaking about negotiations...
Washington, UNITED STATES
U.S. President Trump beckons his guests to join him in the Oval Office after speaking about negotiations...
U.S. President Donald Trump beckons his guests to join him in the Oval Office after speaking about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS3942E
May 26, 2020
U.S. President Donald Trump beckons his guests to join him in the Oval Office after speaking about negotiations...
Washington, UNITED STATES
U.S. President Trump beckons his guests to join him in the Oval Office after speaking about negotiations...
U.S. President Donald Trump beckons his guests to join him in the Oval Office after speaking about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS393ZV
May 26, 2020
U.S. President Donald Trump arrives to speak about negotiations with pharmaceutical companies over the...
Washington, UNITED STATES
U.S. President Trump arrives to speak about negotiations with pharmaceutical companies over the cost...
U.S. President Donald Trump arrives to speak about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS393ZU
May 26, 2020
U.S. President Donald Trump arrives to speak about negotiations with pharmaceutical companies over the...
Washington, UNITED STATES
U.S. President Trump arrives to speak about negotiations with pharmaceutical companies over the cost...
U.S. President Donald Trump arrives to speak about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/USA
RTS393ZT
May 26, 2020
U.S. President Donald Trump arrives to speak about negotiations with pharmaceutical companies over the...
Washington, UNITED STATES
U.S. President Trump arrives to speak about negotiations with pharmaceutical companies over the cost...
U.S. President Donald Trump arrives to speak about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst TPX IMAGES OF THE DAY
HEALTH-CORONAVIRUS/USA
RTS393ZO
May 26, 2020
U.S. President Donald Trump arrives to speak about negotiations with pharmaceutical companies over the...
Washington, UNITED STATES
U.S. President Trump arrives to speak about negotiations with pharmaceutical companies over the cost...
U.S. President Donald Trump arrives to speak about negotiations with pharmaceutical companies over the cost of insulin for U.S. seniors on Medicare at an event in the Rose Garden at the White House during the coronavirus disease (COVID-19) outbreak in Washington, U.S. May 26, 2020. REUTERS/Jonathan Ernst
HEALTH-CORONAVIRUS/BRITAIN
RTX7HC7U
May 05, 2020
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville
HEALTH-CORONAVIRUS/BRITAIN
RTX7HC7M
May 05, 2020
A general view outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
A general view outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville
HEALTH-CORONAVIRUS/BRITAIN-AUTOS
RTX7HC7L
May 05, 2020
A tribute to care workers is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
A tribute to care workers is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville
HEALTH-CORONAVIRUS/BRITAIN
RTX7HC7E
May 05, 2020
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville
HEALTH-CORONAVIRUS/USA
RTX7GF4U
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF4T
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF4N
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF4L
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF4O
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF4M
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/USA
RTX7GF44
April 29, 2020
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational...
Oceanside, UNITED STATES
Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19),...
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/INDIA-DRUGS
RTS34P4D
March 04, 2020
A pharmacist checks weight of Paracetamol, a common pain reliever also sold as acetaminophen, tablets...
Ahmedabad, India
A pharmacist checks weight of Paracetamol tablets inside a lab of a pharmaceutical company on the outskirts...
A pharmacist checks weight of Paracetamol, a common pain reliever also sold as acetaminophen, tablets inside a lab of a pharmaceutical company on the outskirts of Ahmedabad, India, March 4, 2020. REUTERS/Amit Dave
HEALTH-CORONAVIRUS/INDIA-DRUGS
RTS34P4B
March 04, 2020
A pharmacist checks weight of Paracetamol, a common pain reliever also sold as acetaminophen, tablets...
Ahmedabad, India
A pharmacist checks weight of Paracetamol tablets inside a lab of a pharmaceutical company on the outskirts...
A pharmacist checks weight of Paracetamol, a common pain reliever also sold as acetaminophen, tablets inside a lab of a pharmaceutical company on the outskirts of Ahmedabad, India, March 4, 2020. REUTERS/Amit Dave
CHINA-TRADE/EXPO-ASTRAZENECA
RTX77O7Z
November 06, 2019
Pascal Soriot, chief executive officer of pharmaceutical company AstraZeneca, attends an interview with...
Shanghai, China
Pascal Soriot, chief executive officer of pharmaceutical company AstraZeneca, attends an interview with...
Pascal Soriot, chief executive officer of pharmaceutical company AstraZeneca, attends an interview with Reuters in Shanghai, China November 4, 2019. Picture taken November 4, 2019. REUTERS/Brenda Goh
CHINA-TRADE/EXPO-ASTRAZENECA
RTX77O7Y
November 06, 2019
Pascal Soriot, chief executive officer of pharmaceutical company AstraZeneca, attends an interview with...
Shanghai, China
Pascal Soriot, chief executive officer of pharmaceutical company AstraZeneca, attends an interview with...
Pascal Soriot, chief executive officer of pharmaceutical company AstraZeneca, attends an interview with Reuters in Shanghai, China November 4, 2019. Picture taken November 4, 2019. REUTERS/Brenda Goh
FRANCE-ECONOMY/
RTS2OBCK
August 29, 2019
Director of French multinational pharmaceutical company Sanofi for France, Guillaume Leroy, attends the...
Paris, France
Director of French multinational pharmaceutical company Sanofi for France, Guillaume Leroy, attends the...
Director of French multinational pharmaceutical company Sanofi for France, Guillaume Leroy, attends the MEDEF union summer forum renamed La Rencontre des Entrepreneurs de France, LaREF, at the Paris Longchamp racecourse in Paris, France, August 29, 2019. REUTERS/Benoit Tessier
BRITAIN-EU/MEDICINES
RTS2M99G
August 12, 2019
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August...
Brussels, Belgium
Illustration photo shows various medicine pills in their original packaging in Brussels
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August 9, 2019. REUTERS/Yves Herman/Illustration
BRITAIN-EU/MEDICINES
RTS2M99B
August 12, 2019
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August...
Brussels, Belgium
Illustration photo shows various medicine pills in their original packaging in Brussels
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August 9, 2019. REUTERS/Yves Herman/Illustration
BRITAIN-EU/MEDICINES
RTS2M999
August 12, 2019
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August...
Brussels, Belgium
Illustration photo shows various medicine pills in their original packaging in Brussels
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August 9, 2019. REUTERS/Yves Herman/Illustration
BAYER-RESULTS/
RTX71I89
July 30, 2019
The logo of German chemical and pharmaceutical company Bayer is pictured on a billboard for its painkiller...
Leverkusen, Germany
Logo of Bayer is pictured on a billboard for its painkiller Aspirin at the headquarters in Leverkusen...
The logo of German chemical and pharmaceutical company Bayer is pictured on a billboard for its painkiller Aspirin at Bayer AG's headquarters in Leverkusen, near Cologne, Germany, July 29, 2019. Picture taken July 29, 2019. REUTERS/Wolfgang Rattay
BAYER-RESULTS/
RTX71I81
July 30, 2019
The logo of German chemical and pharmaceutical company Bayer is pictured on a billboard for its painkiller...
Leverkusen, Germany
Logo of Bayer is pictured on a billboard for its painkiller Aspirin at the headquarters in Leverkusen...
The logo of German chemical and pharmaceutical company Bayer is pictured on a billboard for its painkiller Aspirin at Bayer AG's headquarters in Leverkusen, near Cologne, Germany, July 29, 2019. Picture taken July 29, 2019. REUTERS/Wolfgang Rattay
SWISS-BUSINESS/
RTX702G6
July 18, 2019
The company logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in front of its headquarters...
PRATTELN, Switzerland
Logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in Pratteln
The company logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in front of its headquarters the Ceres Tower building in Pratteln, Switzerland July 18, 2019. REUTERS/Arnd WIegmann
SWISS-BUSINESS/
RTX702G5
July 18, 2019
The company logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in front of its headquarters...
PRATTELN, Switzerland
Logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in Pratteln
The company logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in front of its headquarters the Ceres Tower building in Pratteln, Switzerland July 18, 2019. REUTERS/Arnd WIegmann
SWISS-BUSINESS/
RTX702G3
July 18, 2019
The company logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in front of its headquarters...
PRATTELN, Switzerland
Logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in Pratteln
The company logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in front of its headquarters the Ceres Tower building in Pratteln, Switzerland July 18, 2019. REUTERS/Arnd WIegmann
SWISS-BUSINESS/
RTX702G0
July 18, 2019
The company logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in front of its headquarters...
PRATTELN, Switzerland
Logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in Pratteln
The company logo of Swiss-based Santhera Pharmaceuticals Holding AG is seen in front of its headquarters in Pratteln, Switzerland July 18, 2019. REUTERS/Arnd WIegmann
KAZAKHSTAN-ANTLERS/
RTX6XLOA
June 02, 2019
Deers graze at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan May 31, 2019. Maral...
Almaty Region, Kazakhstan
Deers graze at maral farm in Kasymbek gorge in Kazakhstan
Deers graze at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan May 31, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken May 31, 2019. REUTERS/Pavel Mikheyev TPX IMAGES OF THE DAY
KAZAKHSTAN-ANTLERS/
RTX6XLDL
June 02, 2019
A breeder drives deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral...
Almaty Region, Kazakhstan
A breeder drives deers at maral farm in Kasymbek gorge in Kazakhstan
A breeder drives deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev TPX IMAGES OF THE DAY
KAZAKHSTAN-ANTLERS/
RTX6XL9I
June 02, 2019
A breeder drives deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral...
Almaty Region, Kazakhstan
A breeder drives deers at maral farm in Kasymbek gorge in Kazakhstan
A breeder drives deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL83
June 02, 2019
A breeder drives deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral...
Almaty Region, Kazakhstan
A breeder drives deers at maral farm in Kasymbek gorge in Kazakhstan
A breeder drives deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL7Y
June 02, 2019
Breeders drive deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral...
Almaty Region, Kazakhstan
Breeders drive deers at maral farm in Kasymbek gorge in Kazakhstan
Breeders drive deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL7S
June 02, 2019
A deer is seen as breeders prepare to cut off his antlers, famous for their strong healing effect, at...
Almaty Region, Kazakhstan
Breeders cut off deer antlers, famous for their strong healing effect, at maral farm in Kazakhstan
A deer is seen as breeders prepare to cut off his antlers, famous for their strong healing effect, at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL7R
June 02, 2019
Breeders cut off deer antlers, famous for their strong healing effect, at "Alatau Maraly" farm in Kasymbek...
Almaty Region, Kazakhstan
Breeders cut off deer antlers, famous for their strong healing effect, at maral farm in Kazakhstan
Breeders cut off deer antlers, famous for their strong healing effect, at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL7P
June 02, 2019
Breeders cut off deer antlers, famous for their strong healing effect, at "Alatau Maraly" farm in Kasymbek...
Almaty Region, Kazakhstan
Breeders cut off deer antlers, famous for their strong healing effect, at maral farm in Kazakhstan
Breeders cut off deer antlers, famous for their strong healing effect, at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL7M
June 02, 2019
A deer is seen at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral...
Almaty Region, Kazakhstan
A deer is seen at maral farm in Kasymbek gorge in Kazakhstan
A deer is seen at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL7L
June 02, 2019
Deers graze at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan May 31, 2019. Maral...
Almaty Region, Kazakhstan
Deers graze at maral farm in Kasymbek gorge in Kazakhstan
Deers graze at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan May 31, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken May 31, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL7K
June 02, 2019
A deer is seen as breeders cut off his antlers, famous for their strong healing effect, at "Alatau Maraly"...
Almaty Region, Kazakhstan
Breeders cut off deer antlers, famous for their strong healing effect, at maral farm in Kazakhstan
A deer is seen as breeders cut off his antlers, famous for their strong healing effect, at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL7D
June 02, 2019
Deers graze at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan May 31, 2019. Maral...
Almaty Region, Kazakhstan
Deers graze at maral farm in Kasymbek gorge in Kazakhstan
Deers graze at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan May 31, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken May 31, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL78
June 02, 2019
Deers graze at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan May 31, 2019. Maral...
Almaty Region, Kazakhstan
Deers graze at maral farm in Kasymbek gorge in Kazakhstan
Deers graze at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan May 31, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken May 31, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL77
June 02, 2019
Cut deer antlers, famous for their strong healing effect, are seen at "Alatau Maraly" farm in Kasymbek...
Almaty Region, Kazakhstan
Cut deer antlers, famous for their strong healing effect, are seen at maral farm in Kazakhstan
Cut deer antlers, famous for their strong healing effect, are seen at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL76
June 02, 2019
A breeder drives deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral...
Almaty Region, Kazakhstan
A breeder drives deers at maral farm in Kasymbek gorge in Kazakhstan
A breeder drives deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL75
June 02, 2019
A breeder drives deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral...
Almaty Region, Kazakhstan
A breeder drives deers at maral farm in Kasymbek gorge in Kazakhstan
A breeder drives deers at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
KAZAKHSTAN-ANTLERS/
RTX6XL74
June 02, 2019
A deer is seen as the breeders cut off his antlers, famous for their strong healing effect, at "Alatau...
Almaty Region, Kazakhstan
Breeders cut off deer antlers, famous for their strong healing effect, at maral farm in Kazakhstan
A deer is seen as the breeders cut off his antlers, famous for their strong healing effect, at "Alatau Maraly" farm in Kasymbek gorge, Almaty region, Kazakhstan June 1, 2019. Maral stags at this private farm undergo an annual cutting off their antlers to be sold to pharmaceutical companies. Picture taken June 1, 2019. REUTERS/Pavel Mikheyev
BAYER-AGM/
RTX6T9A5
April 26, 2019
Environmental activists lie on the ground as they protest against the merger of Germany's pharmaceutical...
Bonn, Germany
Protests ahead of German drug and crop chemical maker Bayer's annual general meeting
Environmental activists lie on the ground as they protest against the merger of Germany's pharmaceutical and chemical maker Bayer AG with U.S. seeds and agrochemicals company Monsanto, during Bayer's annual general shareholders meeting in Bonn, Germany, April 26, 2019. REUTERS/Thilo Schmuelgen TPX IMAGES OF THE DAY
Sort by
Display
Items per page
Page
of 23